Is Ogesip SA (Clone) a Scam?

When we at FXCanary sit down to judge whether a broker is safe, we do not rely on marketing pages or the promises of a sales team. We start with the public regulatory record — the licences, the registries, the official warnings — and we build from there. A broker that holds a credible licence from a major regulator, with a verifiable history and a clear corporate structure, starts with a strong foundation. A broker that does not, starts with a serious question mark.

For Ogesip SA (Clone), the record is almost entirely empty. Our files show no regulator on file, no licence on file, and no verifiable website or social-media presence beyond the domain ogesip-investment.com. The FXCanary Scam Risk Score sits at 55 out of 100, which we classify as 'Elevated'. That score is built directly from two risk flags: no verified regulatory licence, and no verifiable online footprint. In our assessment, those two flags alone are enough to give any prudent trader pause — and they are the foundation of everything that follows in this review.

A regulated broker operates inside a framework of rules. A licensed firm must segregate client funds from its own operating capital, must submit to regular audits, must hold minimum capital, and must answer to a regulator that can investigate and sanction misconduct. When a broker has no licence on file, none of those protections can be assumed. There is no independent body watching over client money, no compensation scheme standing behind a failed withdrawal, and no authority to complain to when things go wrong.

In the case of Ogesip SA (Clone), we could not identify any regulator that oversees this entity. The name itself carries a warning — the '(Clone)' designation indicates that this firm may be impersonating a legitimate company, a practice we see frequently in the forex world. A clone broker borrows the name, and sometimes the branding, of a real firm to appear credible, while operating entirely outside the regulatory net. For a trader, that means the person on the other side of the trade may have no legal obligation to act in your interest, and no regulator will step in if your funds disappear.

When we evaluate a broker's safety, we look closely at how client funds are protected. In a well-regulated environment, client money is typically held in segregated accounts, separate from the broker's own funds, so that even if the broker fails, your deposits should be returned. Many jurisdictions also offer compensation schemes — such as the UK's Financial Services Compensation Scheme or the EU's investor protection frameworks — that guarantee a certain amount of your money even if the broker collapses. And negative balance protection ensures that you cannot lose more than you deposited, even in extreme market moves.

For Ogesip SA (Clone), none of these protections can be confirmed. With no licence on file, there is no evidence of client fund segregation, no compensation scheme, and no negative balance protection. We cannot say these protections are definitively absent — we can only say that there is no regulatory mechanism requiring them. In our view, that uncertainty is itself a red flag. A trader depositing funds with this broker would be doing so without any of the safety nets that a regulated broker is required to provide.

The '(Clone)' label in our records is not incidental — it is central to the risk profile of this entity. Clone firms are a well-documented problem in the financial industry. Regulators around the world, including IOSCO members, regularly issue alerts about unauthorized firms that use names similar to legitimate companies. The International Securities and Commodities Alerts Network (I-SCAN) exists precisely to track these warnings, and it lists thousands of such cases. A clone broker trades on the trust that a legitimate name has built, while offering none of the substance behind it.

In our review, we searched for information on ogesip-investment.com and found very little. The domain appears to have been registered recently, has few visitors, and its content could not be analyzed by automated tools. The web search results we examined returned a range of unrelated brokers — T4Trade, Milton Markets, EGM Securities, and others — none of which match the name or domain of Ogesip SA. This is a common pattern for obscure or newly created entities: they exist in a digital shadow, with little independent footprint to verify their claims. For a trader, that lack of transparency is a warning in itself.

We ran a broad web search for Ogesip SA (Clone) and its domain, ogesip-investment.com. The results were dominated by other brokers with similar-sounding names or adjacent business models — T4Trade, Milton Markets, EGM Securities, API2TRADE, RobotFX, and others. None of these appear to be the same entity as Ogesip SA. The only result that directly referenced the domain was a third-party trust score check, which gave it a low trust score, noted that the website has few visitors, and flagged that it was registered only recently. That aligns with our own assessment: this is a low-information entity with no meaningful independent track record.

We must be clear: the absence of information is not proof of fraud, but it is a significant warning sign. A legitimate broker, even a small one, typically leaves some trace — a corporate registry entry, a regulatory filing, a history of user reviews, or at least a consistent online presence. For Ogesip SA (Clone), we found none of that. In our experience, brokers that operate in this kind of informational vacuum are disproportionately likely to be problematic. We would not trust this entity with a single dollar of client funds without far more evidence of legitimacy.

If you are considering any broker, but especially one like Ogesip SA (Clone) with no verifiable licence, the first step is to check the regulator's own database. Every credible regulator — whether the FCA in the UK, CySEC in Cyprus, or the FSCA in South Africa — maintains a public register of authorized firms. Search for the broker's name and its exact domain.

If you cannot find it, that is a red flag. If you find a similar name but a different domain, that is a classic clone warning sign. Do not rely on the broker's own website to prove its legitimacy; go to the regulator directly.

Second, verify the domain itself. Look at when it was registered and by whom. A domain that is only months old, with no history, is a risk factor.

Third, search for independent reviews and complaints — but be aware that for a broker with no reviews, the silence is telling. In this case, we found no independent user reviews for Ogesip SA (Clone), which means there is no community track record to assess. That is not a neutral fact; it is a gap that should make you more cautious, not less.

Finally, consider the practical realities. If a broker offers terms that seem too good to be true — extremely high leverage, guaranteed returns, or bonuses that appear generous — treat them with suspicion. A regulated broker is constrained in what it can promise; an unregulated one is not. And if you do decide to proceed despite the risks, never deposit more than you can afford to lose entirely. In our assessment, the safest course with Ogesip SA (Clone) is to avoid it altogether until it can demonstrate a verifiable regulatory licence and a transparent operating history.

In FXCanary's assessment, Ogesip SA (Clone) presents an elevated risk profile that we would not recommend for any trader. The absence of a regulatory licence, the lack of a verifiable online presence, and the clone designation all point to an entity that operates outside the protections that legitimate brokers provide. There is no evidence of client fund segregation, no compensation scheme, and no independent oversight. The only information we found about the domain suggests it is new, has few visitors, and has not been thoroughly analyzed — all consistent with a broker that is either very new or deliberately obscure.

We want to be direct: we are not saying that Ogesip SA (Clone) is definitively a scam. We are saying that the evidence available does not support a finding of safety, and that the burden of proof lies with the broker to demonstrate its legitimacy. Until it does, the prudent choice is to steer clear. For traders who value the security of their capital, the absence of a safety net is itself the story. In this case, that absence is the most important fact we can report.